Class I MHC modulation or surface receptor activity

Details Class I MHC modulation or surface receptor activity Class I MHC modulation or surface receptor activity

1993-05-03

1995-01-31

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 8, 514 16, 530300, 530324, 530328, A61K 3702, C07K 706

Patent

active

053858883

ABSTRACT:
Methods and compositions are provided for regulating surface membrane receptor response by modulating the interaction between an MHC Class I antigen and the surface membrane receptor. Various techniques may be employed for enhancing or reducing the interaction between the Class I antigen and surface membrane receptor, e.g., enhancing production of the Class I antigen.

REFERENCES:
patent: 5073540 (1991-12-01), Olsson
Due, C., et al., P.N.A.S. (USA) 83:6007-6011 (Aug. 1986), "The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens".
Fehlmann, M., et al., P.N.A.S. (USA) 82:8634-8637 (Dec., 1985), "Molecular association between major histocompatibility complex class I antigens and insulin receptors in mouse liver membranes".
Gilman, A. G., et al., The Pharmacological Basis of Therapeutics, 8th edition, pp. 1468-1470 (1990).
Kittur, D., et al., P.N.A.S. (USA) 84:1351-1355 (Mar., 1987), "Insulin binding to human B lympoblasts is a function of HLA haplotype".
Lafuse, W., et al., Biochemistry 1:49-54 (1980), "Interaction of the mouse major histocompatibility complex, H-2, on liver adenylate cyclase activity and on glucagon binding to liver cell membranes".
Paul, W. F. (ed), Fundamental Immunology, 2d edition (1989), pp. 652-653.
Phillips, M., et al., P.N.A.S. (USA) 83:3474-3478 (May, 1986, "Class I histocompatibility antigens and insulin receptors: evidence for interactions".
Robbins Pathological Basis of Disease (R. S. Cotran, et al., eds.), 4th edition (1989), pp. 994-1001.
Ruoslahti, E., et al. in Synthetic Peptides in Biology and Medicine, pp. 191-197 (1985), Alitalo, et al (editors), Elsevier Science Publishers B. V. (Biomedical Division), the Netherlands.
Schreiber, A. B., et al., J. Cell Biol. 98:725-731 (Feb., 1984), "Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells".
Simonsen, M., et al., Ann. Immunology (Inst. Pasteur) 134D, pp. 85-92 (1983), "Possible roles of compound membrane receptors in the immune system".

Affiliated with

Also associated with

Rating

Class I MHC modulation or surface receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Class I MHC modulation or surface receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Class I MHC modulation or surface receptor activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1102226